Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia

Ayman A.M. Alameen; Carolina Simioni; Alberto M. Martelli; Giorgio Zauli; Simona Ultimo; James A. McCubrey; Arianna Gonelli; Giorgia Marisi; Paola Ulivi; Silvano Capitani; Luca M. Neri

Oncotarget (2016) - Comments
pubmed: 27494886 doi: 10.18632/oncotarget.10984 issn: 1949-2553

Ayman A.M. Alameen, Carolina Simioni, Alberto M. Martelli, Giorgio Zauli, Simona Ultimo, James A. McCubrey, Arianna Gonelli, Giorgia Marisi, Paola Ulivi, Silvano Capitani, Luca M. Neri

Go to article
Go to preprint

Impact Journals, LLC